TFC Financial Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $144K | Hold |
323
| – | – | 0.02% | 156 |
|
|
2025
Q1 | $157K | Hold |
323
| – | – | 0.02% | 142 |
|
|
2024
Q4 | $130K | Hold |
323
| – | – | 0.02% | 161 |
|
|
2024
Q3 | $150K | Buy |
323
+10
| +3% | +$4.65K | 0.02% | 149 |
|
|
2024
Q2 | $147K | Buy |
313
+162
| +107% | +$75.9K | 0.03% | 144 |
|
|
2024
Q1 | $63.1K | Buy |
151
+1
| +0.7% | +$418 | 0.01% | 214 |
|
|
2023
Q4 | $61K | Hold |
150
| – | – | 0.01% | 211 |
|
|
2023
Q3 | $52.2K | Hold |
150
| – | – | 0.01% | 215 |
|
|
2023
Q2 | $52.8K | Buy |
150
+3
| +2% | +$1.06K | 0.01% | 216 |
|
|
2023
Q1 | $46.3K | Buy |
147
+4
| +3% | +$1.26K | 0.01% | 236 |
|
|
2022
Q4 | $41.3K | Buy |
143
+16
| +13% | +$4.62K | 0.01% | 211 |
|
|
2022
Q3 | $37K | Buy |
127
+18
| +17% | +$5.24K | 0.01% | 215 |
|
|
2022
Q2 | $31K | Buy |
109
+40
| +58% | +$11.4K | 0.01% | 228 |
|
|
2022
Q1 | $18K | Buy |
69
+22
| +47% | +$5.74K | 0.01% | 270 |
|
|
2021
Q4 | $10K | Hold |
47
| – | – | ﹤0.01% | 340 |
|
|
2021
Q3 | $9K | Hold |
47
| – | – | ﹤0.01% | 345 |
|
|
2021
Q2 | $9K | Hold |
47
| – | – | ﹤0.01% | 330 |
|
|
2021
Q1 | $10K | Sell |
47
-18
| -28% | -$3.83K | ﹤0.01% | 312 |
|
|
2020
Q4 | $15K | Sell |
65
-4
| -6% | -$923 | 0.01% | 286 |
|
|
2020
Q3 | $19K | Buy |
+69
| New | +$19K | 0.01% | 238 |
|